Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

What is Genetic Engineering?00:49

What is Genetic Engineering?

80.3K
Overview
80.3K
Therapeutic Index01:13

Therapeutic Index

6.9K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.9K
Structure and Function of Platelets01:18

Structure and Function of Platelets

3.6K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
3.6K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

9.4K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
9.4K
Therapeutic Communication01:30

Therapeutic Communication

8.5K
Communication is a lifelong learning process. Through therapeutic communication, nurses can collect relevant assessment data, provide education and counseling, and interact during nursing interventions. Sending and receiving messages occur through verbal and nonverbal communication techniques and can happen separately or simultaneously.
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
8.5K
Cholinergic Antagonists: Therapeutic Uses01:26

Cholinergic Antagonists: Therapeutic Uses

1.5K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:    
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.5K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Bioresponsive microneedle stent provides anastomosis and postoperative adjuvant therapy in preclinical resectable intestinal diseases.

Science translational medicine·2026
Same author

Electroactive microneedle augmented stem cell therapy in myocardial infarction.

Science advances·2026
Same author

Mammary organoid-based depot for post-surgical chemotherapy and gland regeneration.

Nature biomedical engineering·2026
Same author

Peptide-Based PROTACs: Transitioning from Static Paradigm to a Dynamic Landscape within Targeted Protein Degradation.

Bioconjugate chemistry·2026
Same author

Towards intelligent and miniaturized drug delivery devices.

Nature·2026
Same author

Bioinspired Diffusion-Limited Silicification in Coacervate Assemblies Enables Smart Nanotoroids for Deep and Sensitive Tumor Penetration.

Journal of the American Chemical Society·2026

Video Experimental Relacionado

Updated: Feb 8, 2026

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

1.1K

Ingeniería de plaquetas como terapéutica contra el cáncer

Yu Chen1,2,3, Tyler Wolter1,2,3,4, Zhen Gu5,6,7,8,9

  • 1Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin-Madison, Madison, WI, USA.

Nature reviews. Clinical oncology
|February 6, 2026
PubMed
Resumen

Las plaquetas desempeñan un doble papel en el cáncer, promoviendo o suprimiendo la progresión tumoral. Las plaquetas modificadas genéticamente ofrecen una estrategia terapéutica flexible para el tratamiento del cáncer mediante la reprogramación de su función.

Palabras clave:
plaquetascáncerterapéuticaingenieríaentrega de fármacosinmunoterapia

Más Videos Relacionados

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
05:49

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

1.2K
In vivo Imaging and Therapeutic Treatments in an Orthotopic Mouse Model of Ovarian Cancer
07:46

In vivo Imaging and Therapeutic Treatments in an Orthotopic Mouse Model of Ovarian Cancer

Published on: August 17, 2010

34.6K

Videos de Experimentos Relacionados

Last Updated: Feb 8, 2026

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

1.1K
Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
05:49

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

1.2K
In vivo Imaging and Therapeutic Treatments in an Orthotopic Mouse Model of Ovarian Cancer
07:46

In vivo Imaging and Therapeutic Treatments in an Orthotopic Mouse Model of Ovarian Cancer

Published on: August 17, 2010

34.6K

Área de la Ciencia:

  • Oncología
  • Hematología
  • Biotecnología

Sus antecedentes:

  • Las plaquetas influyen en la progresión del cáncer a través de interacciones celulares, secreción de mediadores y liberación de vesículas extracelulares.
  • Las plaquetas también pueden suprimir tumores modulando la inmunidad o liberando moléculas anticancerígenas.
  • El complejo papel de las plaquetas requiere estrategias terapéuticas avanzadas más allá de la simple inhibición o activación.

Objetivo del estudio:

  • Revisar la comprensión actual de la biología de las plaquetas en el cáncer.
  • Examinar las estrategias de ingeniería para la reprogramación terapéutica de plaquetas.
  • Esbozar las oportunidades y los desafíos para la traslación clínica de plaquetas modificadas genéticamente.

Principales métodos:

  • Revisión de la literatura existente sobre la función de las plaquetas en el cáncer.
  • Análisis de enfoques de ingeniería genética y química para la modificación de plaquetas.
  • Discusión de los requisitos de implementación clínica para terapias de plaquetas modificadas genéticamente.

Principales resultados:

  • Las plaquetas exhiben actividades pro- o antitumorales dependientes del contexto.
  • Las plaquetas modificadas genéticamente pueden ser multifuncionales, actuando como vehículos de administración de fármacos o células efectoras.
  • Los avances en ingeniería permiten la modificación preservando las funciones esenciales de las plaquetas.

Conclusiones:

  • Las plaquetas modificadas genéticamente representan una vía terapéutica prometedora en oncología.
  • Los entornos autólogos y alogénicos ofrecen flexibilidad para las terapias basadas en plaquetas.
  • La traslación clínica requiere abordar las preocupaciones de estabilidad, fabricación y seguridad.